glp-1 savings card Your one spot for affordable pricing — with or without insurance How to Choose the Right

This contraindication applies to semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide extended-release (Bydureon BCise), tirzepatide (Mounjaro, Zepbound), and the combination product Xultophy (insulin degludec/liraglutide)

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)

Why Clinical Support Matters For GLP-1 Success Working with a clinician helps you use GLP-1s safely, manage side effects, and stay accountable

Here, the kidney failed to reabsorb sodium, indicating tubular dysfunction, consistent with intrinsic renal injury

Lancet 393 , 17451759 (2019)